Low-dose prednisolone ameliorates acute renal failure caused by cholesterol crystal embolism

Clinical Nephrology

Volumn 66, Issue 4, 2006, Pages 232-239

  Nakayama, M ^a   Nagata, M ^a   Hirano, T ^a   Sugai, K ^a   Katafuchi, R ^b   Imayama, S ^a   Uesugi, N ^a   Tsuchihashi, T ^a   Kumagai, H ^b  

^a NATIONAL HOSPITAL ORGANIZATION KYUSHU MEDICAL CENTER   (Japan)

^b FUKUOKA RED CROSS HOSPITAL   (Japan)

Author keywords

Acute renal failure; Cholesterol crystal embolism; Low dose corticosteroids

Indexed keywords

CREATININE; PREDNISOLONE;

ACUTE KIDNEY FAILURE; ADULT; AGED; ANGIOCARDIOGRAPHY; APHERESIS; ARTICLE; BRAIN ANGIOGRAPHY; CAUSE OF DEATH; CHOLESTEROL EMBOLISM; CLINICAL ARTICLE; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; EOSINOPHIL COUNT; EOSINOPHILIA; FATALITY; FEMALE; FOLLOW UP; HEMODIALYSIS; HUMAN; KIDNEY FUNCTION; LOW DRUG DOSE; LUNG CANCER; MAINTENANCE THERAPY; MALE; MULTIPLE ORGAN FAILURE; RECURRENT DISEASE; RETREATMENT; TREATMENT DURATION; TREATMENT OUTCOME;

EID: 33749637161     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/cnp66232     Document Type: Article

References (30)

1. Belenfant X, Meyrier A, Jacquot C. Supportive treatment improves survival in multivisceral cholesterol crystal embolism. Am J Kidney Dis. 1999; 33: 840-850.
2. Cabili S, Hochman I, Goor Y. Reversal of gangrenous lesion in the blue toe syndrome with lovastatin - a case report. Angiology. 1993; 44: 821-825.
3. Case Records of Massachusetts General Hospital. Case 34-1991. N Engl J Med. 1991; 325: 563-572.
4. Colt HG, Begg RJ, Saporito JJ, Cooper WM, Shapiro AP. Cholesterol emboli after cardiac catheterization. Eight cases and a review of the literature. Medicine. 1988; 67: 389-400.
5. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery. 1989; 105: 737-746.
6. Dupont PJ, Lightstone L, Clutterbuck EJ et al. Lesson of the week: cholesterol emboli syndrome. Br Med J. 2000; 321: 1065-1067.
7. Fabbian F, Catalano C, Lambertini D, Bordin V, Di Landro D. A possible role of corticosteroids in cholesterol embolization. Nephron. 1999; 83: 189-190.
8. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: A review of 221 cases in the English literature. Angiology. 1987; 38: 769-784.
9. Fukumoto Y, Tsutsui H, Tsuchihasi M, Masumoto A, Takeshita A. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol. 2003; 42: 211-216.
10. Graziani G, Santostasi S, Angelini C, Badalamenti S. Corticosteroids in cholesterol emboli syndrome. Nephron. 2001; 87: 371-373.
11. Hasegawa M, Kawashima S, Shikano M et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. Am J Nephrol. 2000; 20: 263-267.
12. Kasinath BS, Lewis EJ. Eosinophilia as a clue to the diagnosis of atheroembolic renal disease. Arch Intern Med. 1987; 147: 1384-1385.
13. Kaufman JL, Stark K, Brolin BE. Disseminated atheroemboli from extensive degenerative atherosclerosis of aorta. Surgery. 1987; 102: 63-70.
14. Koga J, Ohno M, Okamoto K et al. Cholesterol embolization treated with corticosteroids. Two case reports. Angiology. 2005; 56: 497-501.
15. Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol. 1993; 13: 489-493.
16. Manganoni AM, Venturini M, Scolari F et al. The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. Br J Dermatol. 2004; 150: 1230-1231.
17. Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens. 2001; 14: 831-834.
18. Maurizi CP, Barker AE, Truehart RE. Atheromatous emboli: a postmortem study with special reference to the lower extremities. Arch Pathol. 1968; 86: 528-534.
19. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol. 2001; 12: 1781-1787.
20. Nakahama H, Sakaguchi K. Small dose oral corticosteroid treatment rapidly improved renal function in a patient with acute aggravation of chronic renal failure due to cholesterol embolism. Nephrol Dial Transplant. 2001; 16: 872-873.
21. Ramirez G, O'Neil WM, Lambert R, Bloomer HA. Cholesterol embolization: a complication of angiography. Arch Intern Med. 1978; 138: 1430-1432.
22. Scoble JE, O'Donnell PJ. Renal atheroembolic disease: the Cinderella of nephropathy? Nephrol Dial Transplant. 1996; 11: 1516-1517.
23. Scolari F, Bracchi M, Valzorio B et al. An increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. 1996; 11: 1607-1612.
24. Scolari F, Ravani P, Pola A et al. Predictors of renal and patient outcomes in atheroembolic renal disease: A prospective study. J Am Soc Nephrol. 2003; 14: 1584-1590.
25. Smith MC, Ghose MK, Henry AR. The clinical spectrum of renal cholesterol embolization. Am J Med. 1981; 71: 174-180.
26. Snyder HE, Shapiro JL. A corrective study of atheromatous embolism in human beings and experimental animals. Surgery. 1961; 49: 195-204.
27. Takahashi T, Konta T, Nishida W, Igarashi A, Ichikawa K, Kubota I. Renal cholesterol embolic disease effectively treated with steroid pulse therapy. Intern Med. 2003; 42: 1206-1209.
28. Thadhani RI, Camargo Jr CA, Xavier RJ, Fang LS, Bazari H. Atheroembolic renal failure after invasive procedures: Natural history based on 52 histologically proven cases. Medicine. 1995; 74: 350-358.
29. Vacher-Coponat H, Pache X, Dussol B, Berland Y. Pulmonary-renal syndrome responding to corticosteroids: consider cholesterol embolization. Nephrol Dial Transplant. 1997; 12: 1977-1979.
30. Woofson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet. 1998; 351: 331-332.